The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophilia Source: Eur Respir J 2014; 44: 239-241 Year: 2014
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
IL-33 in patients with severe uncontrolled allergic asthma Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017
Zinc in serum and induced sputum of patients with allergic rhinitis and allergic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004
Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism. Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020
Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006
Effect of adding montelukast on asthma and rhinitis in asthma patients with concomitant allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 121s Year: 2006
Iron in serum and induced sputum of patients with allergic rhinitis and allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006
Persistency of treatment response to omalizumab in patients with severe allergic (IgE-mediated) asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Mast cells are associated with exacerbations and eosinophilia in children with severe asthma Source: Eur Respir J 2016; 48: 1320-1328 Year: 2016
Immunotherapy prevents the development of asthma in subjects with allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001
Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Inflammatory profile of patients with allergic asthma & rhinitis versus patients with allergic rhinitis alone Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients Year: 2007
Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype Source: Virtual Congress 2021 – Advances in childhood asthma: biologics, biomarkers and infections Year: 2021
The role of mast cells in allergic, non-allergic and aspirin-induced asthma and rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 589s Year: 2005
Effect of corticosteroids on lymphocytes from severe asthma patients Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012
The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004
Platelet function in allergic asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 352s Year: 2004
Anti-IgE therapy with omalizumab decreases exacerbations in patients with poorly controlled moderate-to-severe allergic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 203s Year: 2003
Omalizumab decreases IgE production in patients with severe allergic asthma Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012